ArticleJournal of clinical medicine2022

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer.

Yunha Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.